Association between TLR2 and TLR4 gene polymorphisms and the susceptibility to inflammatory bowel disease: A meta-analysis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Cheng, Yang ^a   Zhu, Yun ^a   Huang, Xiuping ^a   Zhang, Wei ^a   Han, Zelong ^a   Liu, Side ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ALLELE MODEL; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; CAUCASIAN; CROHN DISEASE; DATA EXTRACTION; DNA POLYMORPHISM; DOMINANT MODEL; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC PARAMETERS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HARDY WEINBERG EQUILIBRIUM; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INFLAMMATORY BOWEL DISEASE; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS; TLR2 GENE; TLR4 GENE; ULCERATIVE COLITIS; ADOLESCENT; ADULT; AGED; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; ODDS RATIO;

ADOLESCENT; ADULT; AGED; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84932618647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126803     Document Type: Article

References (65)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142(1):46-54 e42; quiz e30. Epub 2011/10/18. doi: 10.1053/j.gastro.2011.10.001 PMID: 22001864.
2. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nature reviews Immunology. 2008; 8(6):458-66. Epub 2008/05/27. doi: 10.1038/nri2340 PMID: 18500230.
3. Weterman IT, Pena AS. Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology. 1984; 86(3):449-52. Epub 1984/03/01. PMID: 6693011.
4. Rodriguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World journal of gastroenterology: WJG. 2007; 13(42):5560-70. Epub 2007/10/24. PMID: 17948929; PubMed Central PMCID: PMCPMC4172734.
5. Seitz M. Toll-like receptors: sensors of the innate immune system. Allergy. 2003; 58(12):1247-9. Epub 2003/11/18. PMID: 14616098.
6. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proceedings of the National Academy of Sciences of the United States of America. 1998; 95(2):588-93. Epub 1998/01/22. PMID: 9435236; PubMed Central PMCID: PMCPMC18464.
7. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity. 1999; 11(4):443-51. Epub 1999/11/05. PMID: 10549626.
8. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797):782-7. Epub 2000/08/30. doi: 10.1038/35021228 PMID: 10963608.
9. Singh JC, Cruickshank SM, Newton DJ, Wakenshaw L, Graham A, Lan J, et al. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis. American journal of physiology Gastrointestinal and liver physiology. 2005; 288(3):G514-24. Epub 2004/10/23. doi: 10.1152/ajpgi.00377.2004 PMID: 15499080.
10. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infection and immunity. 2000; 68(12):7010-7. Epub 2000/11/18. PMID: 11083826; PubMed Central PMCID: PMCPMC97811.
11. Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. The Journal of experimental medicine. 2003; 197(12):1787-91. Epub 2003/06/11. doi: 10.1084/jem.20022078 PMID: 12796470; PubMed Central PMCID: PMCPMC2193949.
12. Hausmann M, Kiessling S, Mestermann S, Webb G, Spottl T, Andus T, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology. 2002; 122(7):1987-2000. Epub 2002/06/11. PMID: 12055604.
13. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nature genetics. 2002; 30(1):97-101. Epub 2001/12/04. doi: 10.1038/ng786 PMID: 11731797.
14. Thakkinstian A, D'Este C, Eisman J, Nguyen T, Attia J. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2004; 19(3):419-28. Epub 2004/03/26. doi: 10.1359/jbmr.0301265 PMID: 15040830.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003; 327(7414):557-60. Epub 2003/09/06. doi: 10.1136/bmj.327.7414.557. PMID: 12958120; PubMed Central PMCID: PMCPMC192859.
16. Brittain EH, Fay MP, Follmann DA. A valid formulation of the analysis of noninferiority trials under random effects meta-analysis. Biostatistics (Oxford, England). 2012; 13(4):637-49. Epub 2012/04/03. doi: 10.1093/biostatistics/kxs006 PMID: 22467938; PubMed Central PMCID: PMCPMC3658490.
17. Chootrakool H, Shi JQ, Yue R. Meta-analysis and sensitivity analysis for multi-arm trials with selection bias. Statistics in medicine. 2011; 30(11):1183-98. Epub 2011/05/04. doi: 10.1002/sim.4143 PMID: 21538449.
18. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians. 2012; 62 (1):10-29. Epub 2012/01/13. doi: 10.3322/caac.20138 PMID: 22237781.
19. Munafo MR, Clark TG, Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry research. 2004; 129(1):39-44. Epub 2004/12/02. doi: 10.1016/j.psychres.2004.06.011 PMID: 15572183.
20. Song F, Gilbody S. Bias in meta-analysis detected by a simple, graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. BMJ (Clinical research ed). 1998; 316 (7129):471. Epub 1998/03/11. PMID: 9492690; PubMed Central PMCID: PMCPMC2665616.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315(7109):629-34. Epub 1997/10/06. PMID: 9310563; PubMed Central PMCID: PMCPMC2127453.
22. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. Epub 2000/07/06. PMID: 10877304.
23. Okayama N, Fujimura K, Suehiro Y, Hamanaka Y, Fujiwara M, Matsubara T, et al. Simple genotype analysis of the Asp299Gly polymorphism of the Toll-like receptor-4 gene that is associated with lipopolysaccharide hyporesponsiveness. Journal of clinical laboratory analysis. 2002; 16(1):56-8. Epub 2002/02/09. PMID: 11835533.
24. Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes and immunity. 2004; 5(5):417-25. Epub 2004/06/11. doi: 10.1038/sj.gene.6364111 PMID: 15190267.
25. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004; 53(7):987-92. Epub 2004/06/15. PMID: 15194649; PubMed Central PMCID: PMCPMC1774122.
26. Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflammatory bowel diseases. 2005; 11(7):645-52. Epub 2005/06/24. PMID: 15973118.
27. Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, et al. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. The American journal of gastroenterology. 2005; 100(12):2730-6. Epub 2006/01/06. doi: 10.1111/j.1572-0241.2005.00325.x PMID: 16393227.
28. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World journal of gastroenterology: WJG. 2005; 11(5):681-5. Epub 2005/01/19. PMID: 15655821; PubMed Central PMCID: PMCPMC4250738.
29. Ouburg S, Mallant-Hent R, Crusius JB, van Bodegraven AA, Mulder CJ, Linskens R, et al. The toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway. Gut. 2005; 54(3):439-40. Epub 2005/02/16. PMID: 15710998; PubMed Central PMCID: PMCPMC1774408.
30. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clinical immunology (Orlando, Fla). 2004; 112(1):85-91. Epub 2004/06/23. doi: 10.1016/j.clim.2004.03.002 PMID: 15207785.
31. Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, et al. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. Journal of molecular medicine (Berlin, Germany). 2005; 83(8):601-9. Epub 2005/07/13. doi: 10.1007/s00109-005-0685-x. PMID: 16010583.
32. Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflammatory bowel diseases. 2005; 11 (6):567-75. Epub 2005/05/21. PMID: 15905704.
33. Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World journal of gastroenterology: WJG. 2005; 11(10):1489-95. Epub 2005/03/17. PMID: 15770725; PubMed Central PMCID: PMCPMC4305691.
34. Figueroa C, Peralta A, Herrera L, Castro P, Gutierrez A, Valenzuela J, et al. NOD2/CARD15 and Tolllike 4 receptor gene polymorphism in Chilean patients with inflammatory bowel disease. European cytokine network. 2006; 17(2):125-30. Epub 2006/07/15. PMID: 16840031.
35. Pierik M, Joossens S, Van Steen K, Van Schuerbeek N, Vlietinck R, Rutgeerts P, et al. Toll-like receptor-1,-2, and-6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflammatory bowel diseases. 2006; 12(1):1-8. Epub 2005/12/24. PMID: 16374251.
36. Xiong L-F, Xia B, Jiang L, Guo Q-S, Sun Z-Q. No association of TLR4 gene Asp299Gly, TLR2 gene Arg753Glu and Arg677Trp polymorphisms with inflammatiory bowel disease in Chinese Han Population of Hubei Province(Chinese). World Chinese Journal of Digestology. 2006; 14(2):212-25.
37. Yi Jiang X-YM, Ding-Liang Z, Wen-Xing W, Xuan-Ping X. The association between Toll-like receptor-4 gene Asp299Gly polymorphism and ulcerativecolitis and colorectal adenocarcinoma(Chinese). Chin J Intern. 2006; 45(7):585-6.
38. Hui-Ping Xue P-HN, Wu J-M, Tong J-F. Gene polymorphisms of Toll like receptors in inflammatory bowel disease and their distributionin different populations(Chinese). Journal of Shanghai Jiaotong University(Medical Science). 2007; 27(10):1226-31.
39. Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut. 2007; 56(11):1536-42. Epub 2007/06/28. doi: 10.1136/gut.2007.125468 PMID: 17595233; PubMed Central PMCID: PMCPMC2095669.
40. Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW. TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort. Journal of gastroenterology and hepatology. 2007; 22(11):1760-6. Epub 2007/10/05. doi: 10.1111/j.1440-1746.2006.04727.x PMID: 17914947.
41. Baumgart DC, Buning C, Geerdts L, Schmidt HH, Genschel J, Fiedler T, et al. The c.1-260CT promoter variant of CD14 but not the c.896AG (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Digestion. 2007; 76(3-4):196-202. Epub 2008/01/05. doi: 10.1159/000112646 PMID: 18174680.
42. Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, et al. Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. The American journal of gastroenterology. 2007; 102(11):2504-12. Epub 2007/09/14. doi: 10.1111/j.1572-0241.2007.01463.x PMID: 17850411.
43. Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World journal of gastroenterology: WJG. 2008; 14(28):4454-61. Epub 2008/08/06. PMID: 18680223; PubMed Central PMCID: PMCPMC2731270.
44. Hume GE, Fowler EV, Doecke J, Simms LA, Huang N, Palmieri O, et al. Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population. Inflammatory bowel diseases. 2008; 14(5):585-90. Epub 2008/01/24. doi: 10.1002/ibd.20362 PMID: 18213697.
45. Akin H, Ozdemir FT, Atug O, Tahan G, Eren F, Baca B, et al. Association between Toll-like 4, cd14 polymorphisms and inflammatory bowel disease in Turkish population. Gastroenterology. 2008; 134(4): A465-A. PMID: WOS:000255101503323.
46. Lappalainen M, Halme L, Turunen U, Saavalainen P, Einarsdottir E, Farkkila M, et al. Association of IL23R, TNFRSF1A, and HLA-DRB1 0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflammatory bowel diseases. 2008; 14(8):1118-24. Epub 2008/03/15. doi: 10.1002/ibd.20431 PMID: 18338763.
47. Ye BD, Yang SK, Song K, Yang DH, Yoon SM, Kim KJ, et al. [Association of Toll-like receptor gene with Crohn's disease in Koreans]. The Korean journal of gastroenterology=Taehan Sohwagi Hakhoe chi. 2009; 54(6):377-83. Epub 2009/12/23. PMID: 20026892.
48. Zouiten-Mekki L, Kharrat M, Karoui S, Serghimi M, Fekih M, Matri S, et al. Tolllike receptor 4 (TLR4) polymorphisms in Tunisian patients with Crohn's disease: genotype-phenotype correlation. BMC gastroenterology. 2009; 9:62. Epub 2009/08/12. doi: 10.1186/1471-230x-9-62 PMID: 19664207; PubMed Central PMCID: PMCPMC2736969.
49. Queiroz DM, Oliveira AG, Saraiva IE, Rocha GA, Rocha AM, das Gracas Pimenta Sanna M, et al. Immune response and gene polymorphism profiles in Crohn's disease and ulcerative colitis. Inflammatory bowel diseases. 2009; 15(3):353-8. Epub 2008/10/24. doi: 10.1002/ibd.20757 PMID: 18942754.
50. Bueno de Mesquita M, Ferrante M, Henckaerts L, Joossens M, Janssens V, Hlavaty T, et al. Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. European journal of pediatrics. 2009; 168(5):575-83. Epub 2008/08/02. doi: 10.1007/s00431-008-0798-7 PMID: 18670786.
51. Wagner J, Sim WH, Ellis JA, Ong EK, Catto-Smith AG, Cameron DJ, et al. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PloS one. 2010; 5(11):e15376. Epub 2010/11/17. doi: 10.1371/journal.pone.0015376 PMID: 21079743; PubMed Central PMCID: PMCPMC2975706.
52. Shen XY, Shi RH, Wang Y, Zhang HJ, Zhou XQ, Shen FC, et al. [Toll-like receptor gene polymorphisms and susceptibility to inflammatory bowel disease in Chinese Han and Caucasian populations]. Zhonghua yi xue za zhi. 2010; 90(20):1416-20. Epub 2010/07/22. PMID: 20646633.
53. Chen L. Correlation of ATG16L1, TLR4 and TLR2 gene polymorphisms with inflammatory bowel disease in Zhuang population in GUANGXI province: Guangxi Medical University; 2011.
54. Sivaram G, Tiwari SK, Bardia A, Anjum F, Vishnupriya S, Habeeb A, et al. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis. Human immunology. 2012; 73(2):201-5. Epub 2011/12/24. doi: 10.1016/j.humimm.2011.12.006 PMID: 22192785.
55. Azzam N, Nounou H, Alharbi O, Aljebreen A, Shalaby M. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease. International journal of molecular sciences. 2012; 13(4):4268-80. Epub 2012/05/19. doi: 10.3390/ijms13044268 PMID: 22605977; PubMed Central PMCID: PMCPMC3344213.
56. Kim EJ, Chung WC, Lee KM, Paik CN, Jung SH, Lee BI, et al. Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population. Journal of Korean medical science. 2012; 27(1):72-7. Epub 2012/01/06. doi: 10.3346/jkms.2012.27.1.72 PMID: 22219617; PubMed Central PMCID: PMCPMC3247778.
57. Guagnozzi D, Pagnini C, Delle Fave G, Corleto VD. CARD15 and Toll-like receptor 4 mutations in Italian patients with inflammatory bowel disease. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2012; 44(9):800-1. Epub 2012/05/11. doi: 10.1016/j.dld.2012.03.024 PMID: 22571967.
58. Manolakis AC, Kapsoritakis AN, Kapsoritaki A, Tiaka EK, Oikonomou KA, Lotis V, et al. Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity. Digestive diseases and sciences. 2013; 58(2):371-80. Epub 2012/08/25. doi: 10.1007/s10620-012-2348-4 PMID: 22918682.
59. Budarf ML, Labbe C, David G, Rioux JD. GWA studies: rewriting the story of IBD. Trends in genetics: TIG. 2009; 25(3):137-46. Epub 2009/02/17. doi: 10.1016/j.tig.2009.01.001 PMID: 19217684.
60. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012; 491(7422):119-24. Epub 2012/11/07. doi: 10.1038/nature11582 PMID: 23128233; PubMed Central PMCID: PMCPMC3491803.
61. Yang SK, Hong M, Zhao W, Jung Y, Baek J, Tayebi N, et al. Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut. 2014; 63(1):80-7. Epub 2013/07/16. doi: 10.1136/gutjnl-2013-305193 PMID: 23850713.
62. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011; 140(6):1704-12. Epub 2011/05/03. doi: 10.1053/j.gastro.2011.02.046 PMID: 21530736.
63. Coelho T, Andreoletti G, Ashton JJ, Pengelly RJ, Gao Y, RamaKrishnan A, et al. Immuno-genomic profiling of patients with inflammatory bowel disease: a systematic review of genetic and functional in vivo studies of implicated genes. Inflammatory bowel diseases. 2014; 20(10):1813-9. Epub 2014/08/30. doi: 10.1097/mib.0000000000000174 PMID: 25171511.
64. Mathew CG. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nature reviews Genetics. 2008; 9(1):9-14. Epub 2007/10/31. doi: 10.1038/nrg2203 PMID: 17968351.
65. Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, Chan FK, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflammatory bowel diseases. 2012; 18(6):1164-76. Epub 2011/09/03. doi: 10.1002/ibd.21845 PMID: 21887729.